Clinical Trials Directory

Trials / Completed

CompletedNCT01348984

Study of Transdermal Fentanyl Patch to Treat Postoperative Pain in Total Knee Arthroplasty

Transdermal Fentanyl Patch for Postoperative Analgesia in Total Knee Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Khon Kaen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether transdermal fentanyl patch

Detailed description

Total knee arthroplasty (TKA) has severe postoperative pain that prevents mobilization of patient. The best standard analgesia regimen is patient-control analgesia (PCA) which requires a PCA pump that is expensive. Transdermal fentanyl patch (TFP)(50 mcg/hr) can release fentanyl into blood circulation at rate 50 mcg/hr for three days. It has slow onset of about 12-14 hours, so it's used to treat chronic pain, not popular for a cure of pain. If the investigators apply TFP at appropriate times, i.e. 12-14 hours before surgery, it may be used to treat acute postoperative pain. If it can give good analgesia for TKA, it can replace PCA. The benefit is that it is much cheaper and more convenient.

Conditions

Interventions

TypeNameDescription
DRUGtransdermal fentanyl patchTFP = transdermal fentanyl patch (50 microgram/hour)
DRUGplacebo patchgroup 2 = placebo patch

Timeline

Start date
2010-04-01
Primary completion
2010-10-01
Completion
2010-12-01
First posted
2011-05-06
Last updated
2011-05-06

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01348984. Inclusion in this directory is not an endorsement.